Cempra is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs. Two antibiotic products in development, both focused on the treatment of infectious diseases, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. Cempra is committed to developing commercially and medically differentiated products that provide a treatment alternative to address patient needs. Cempra is led by a management team with extensive drug development and commercialization experience in the area of anti-infectives. The company is supported by a world-class Scientific Advisory Board comprised of renowned industry and infectious disease experts.
Cempra submitted a New Drug Application (NDA) for one of its products, solithromycin, to the FDA in May and hopes to gain approval by the end of 2016. In anticipation of approval, Cempra is in the process of building our first field-based commercial sales organization while expanding our corporate office presence to support this new growth. We welcome you to explore our open career opportunities below.
Software Powered by iCIMS